Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles

BACKGROUND: Efficient target-specific siRNA delivery has always been a primary concern in the field of siRNA clinical application. PURPOSE: In this study, four different types of anti-epidermal growth factor receptor (EGFR) antibody-conjugated immunonanoparticles were prepared and tested for cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jung Seok, Kim, Min Woo, Kang, Seong Jae, Jeong, Hwa Yeon, Park, Sang Il, Lee, Yeon Kyung, Kim, Hong Sung, Kim, Keun Sik, Park, Yong Serk
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118344/
https://www.ncbi.nlm.nih.gov/pubmed/30214190
http://dx.doi.org/10.2147/IJN.S161932

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118344/
https://www.ncbi.nlm.nih.gov/pubmed/30214190
http://dx.doi.org/10.2147/IJN.S161932

Ejemplares similares